Although our study is novel in its assessment of FGF23 in the pediatric ARDS population, it has some limitations, including a lack of IL-6 concentrations in all patients and possible contributions from unmeasured ARDS-relevant factors. The gene discussed is FGF23; the disease is acute respiratory distress syndrome.